This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Afya (AFYA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Afya (AFYA) delivered earnings and revenue surprises of 17.02% and 6.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Roblox (RBLX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Roblox (RBLX) delivered earnings and revenue surprises of 18.87% and 0.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Universal Technical Institute (UTI) Lags Q2 Earnings Estimates
by Zacks Equity Research
Universal Technical (UTI) delivered earnings and revenue surprises of -6.67% and 4.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Lincoln Educational Services Corporation (LINC) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lincoln Educational Services (LINC) delivered earnings and revenue surprises of 200% and 6.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AFYA vs. LOPE: Which Stock Is the Better Value Option?
Afya (AFYA) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
The latest trading day saw Afya (AFYA) settling at $18.13, representing a -1.47% change from its previous close.
Afya (AFYA) Laps the Stock Market: Here's Why
by Zacks Equity Research
Afya (AFYA) closed at $20.74 in the latest trading session, marking a +1.52% move from the prior day.
Lifetime Brands (LCUT) Misses Q4 Earnings Estimates
by Zacks Equity Research
Lifetime Brands (LCUT) delivered earnings and revenue surprises of -9.38% and 3.39%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Toro (TTC) Lags Q1 Earnings Estimates
by Zacks Equity Research
Toro (TTC) delivered earnings and revenue surprises of -3.03% and 0.50%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $20.23, moving -0.3% from the previous trading session.
Why Afya (AFYA) Dipped More Than Broader Market Today
by Zacks Equity Research
In the most recent trading session, Afya (AFYA) closed at $20.44, indicating a -0.68% shift from the previous trading day.
Strategic Education (STRA) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Strategic Education (STRA) delivered earnings and revenue surprises of 22.63% and 1.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Afya (AFYA) reachead $20.05 at the closing of the latest trading day, reflecting a +0.3% change compared to its last close.
Afya (AFYA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Afya (AFYA) closed the most recent trading day at $19.85, moving +1.17% from the previous trading session.
Afya (AFYA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $20.51, signifying a +1.13% move from its prior day's close.
Afya (AFYA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Afya (AFYA) stood at $21.02, denoting a +0.57% change from the preceding trading day.
Afya (AFYA) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
Afya (AFYA) closed at $20.44 in the latest trading session, marking a +1.79% move from the prior day.
PRDO or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
PRDO vs. AFYA: Which Stock Is the Better Value Option?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
Wall Street Analysts Think Afya (AFYA) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Afya (AFYA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PRDO or AFYA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PRDO vs. AFYA: Which Stock Is the Better Value Option?
Afya (AFYA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Afya (AFYA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Afya (AFYA) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Afya (AFYA) stood at $17.49, denoting a +1.92% change from the preceding trading day.
Afya (AFYA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $17.16, signifying a +0.35% move from its prior day's close.
Afya (AFYA) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Afya (AFYA) concluded the recent trading session at $16.10, signifying a -0.86% move from its prior day's close.